Barclays analyst Julian Mitchell is bullish on GE Vernova because of the company's exposure to booming demand for power-generation and electricity-transmission technologies.
The U.K. should encourage more companies to switch their listings from Britain's junior markets to the main board of the London Stock Exchange, Barclays said in a report
Barclays is finding it difficult to sell a stake in its British merchant payments business due to diverging views on its valuation, four people with knowledge of the matter told Reuters, complicating the bank's plans to revamp the unit.
UK bank shares were lifted after the regulator set out watered-down rules on the implementation of capital requirements and lending to small businesses, homeowners and for infrastructure projects. The Prudential Regulation Authority (PRA) published its 'near-final' ruling on how the so-called Basel III regime will be implemented for larger banks, which was initiated in the wake of the 2008 fin...
New rules to ease lending have been unveiled by the Bank of England with small businesses and mortgage funding set to get a boost. Shares in Lloyds Banking Group PLC (LSE:LLOY), Barclays, Natwest and HSBC all rose by more than 1% on the news, which follows years of wrangling on how much money banks needed to protect themselves from collapse after the 2008 financial crisis.
Savers in Britain are sitting on some £430 billion worth of uninvested cash, according to research from Barclays PLC (LSE:BARC). This places the roughly 13 million adults at risk of missing out on higher returns from putting their cash to work, the bank said in a report.
Zara owner Inditex underlined its credentials with a steady second quarter numbers and strong trading currently, said analysts at Barclays. Second quarter numbers were slightly ahead of consensus, said the bank, with resilient top-line growth, increased profitability and lower inventory.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.